High linoleic acid diet reduces plasma EPA and oxylipin mediators in healthy adults
This study was a 12-week randomized controlled trial involving 52 healthy adults who completed the intervention. Participants were assigned to either a high linoleic acid diet (10.0% energy) or a low linoleic acid diet (2.5% energy), with the primary outcomes being plasma highly unsaturated fatty acid concentrations and ex vivo zymosan-stimulated whole-blood oxylipin generation. The setting, study phase, and publication type were not reported.
Main results showed that the high linoleic acid diet led to a marked reduction in plasma n-3 eicosapentaenoic acid concentrations compared to the low linoleic acid diet, though exact numbers, effect sizes, and p-values or confidence intervals were not reported. There was no difference in arachidonic acid, dihomo-gamma-linolenic acid, or docosahexaenoic acid levels between the groups. Additionally, EPA-derived relative to ARA-derived oxylipin mediators were significantly reduced in the high linoleic acid arm.
Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. A key limitation is that controlled dietary intervention studies directly evaluating the biological consequences of varying linoleic acid exposure remain limited. Funding or conflicts of interest were not reported. Practice relevance was not specified, so these findings should be considered preliminary and require further validation in broader populations.